U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
140581140581Probiotics for Eradication of Carbapenem Resistant Klebsiella PneumoniaNot yet recruitingNo Results AvailableAnti-Biotic Resistance|Klebsiella PneumoniaeDietary Supplement: VSL#3|Drug: Polyethylene glycolhttps://ClinicalTrials.gov/show/NCT00722410
140582140582TODAY Genetics StudyCompletedNo Results AvailableType 2 Diabeteshttps://ClinicalTrials.gov/show/NCT00722397
140583140583Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5CompletedNo Results AvailableMacular DegenerationDrug: bevasiranib|Drug: bevasiranibhttps://ClinicalTrials.gov/show/NCT00722384
140584140584MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)CompletedHas ResultsType 2 Diabetes MellitusDrug: Sitagliptin phosphate|Drug: Pioglitazone hydrochloride|Drug: Matching placebo to sitagliptin|Drug: Matching placebo to pioglitazone|Drug: Metforminhttps://ClinicalTrials.gov/show/NCT00722371
140585140585A Multiple Ascending Dose Study of BMS-650032 in HCV Infected SubjectsCompletedNo Results AvailableChronic Hepatitis CDrug: BMS-650032|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00722358
140586140586Exercise Consultation in Obese YouthCompletedNo Results AvailableObesityBehavioral: review of "Canada's Physical Activity Guide for Youth"|Behavioral: Exercise consultationhttps://ClinicalTrials.gov/show/NCT00722345
140587140587Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant PatientsCompletedNo Results AvailableHepatitis B|Liver TransplantationBiological: HepaGam Bhttps://ClinicalTrials.gov/show/NCT00722332
140588140588Ongoing WARfarin and Coronary STENTingActive, not recruitingNo Results AvailableAcute Coronary Syndrome|Atrial Fibrillationhttps://ClinicalTrials.gov/show/NCT00722319
140589140589A Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0200390 In Six Healthy Male VolunteersCompletedNo Results AvailableInsomniaDrug: PD 0200390https://ClinicalTrials.gov/show/NCT00722306
140590140590A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid TumorsCompletedNo Results AvailableNeoplasms, BreastDrug: Doxorubicin|Drug: Pazopanib (GW786034)|Drug: Epirubicinhttps://ClinicalTrials.gov/show/NCT00722293
140591140591Human Upper Extremity (Hand and Forearm) AllotransplantationRecruitingNo Results AvailableAmputation, TraumaticProcedure: Hand Transplantationhttps://ClinicalTrials.gov/show/NCT00722280
140592140592European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNo Results AvailableChronic Obstructive Pulmonary Disease (COPD)https://ClinicalTrials.gov/show/NCT00722267
140593140593Reversible Secondary Myelofibrosis or Clonal Myeloproliferative DisorderWithdrawnNo Results AvailablePrimary Myelofibrosis|Primary Pulmonary Hypertension|Secondary Myelofibrosis|Pulmonary Arterial Hypertensionhttps://ClinicalTrials.gov/show/NCT00722254
140594140594Effectiveness and Safety Study of the Next-Generation DexCom™ SEVEN® Continuous Glucose Monitoring SystemCompletedNo Results AvailableDiabetes Mellitus, Type 1|Diabetes Mellitus, Type 2https://ClinicalTrials.gov/show/NCT00722241
140595140595Allogeneic Whole Cell Cancer Vaccine for Metastatic Epithelial TumorsNot yet recruitingNo Results AvailableColorectal Cancer|Ovarian Cancer|Gastric Cancer|Breast Cancer|Lung CancerBiological: Allogeneic whole epithelial tumor cells, DNP-conjugated and irradiatedhttps://ClinicalTrials.gov/show/NCT00722228
140596140596Endothelin Receptor Antagonism in Proteinuric NephropathyCompletedNo Results AvailableChronic Kidney Disease|ProteinuriaDrug: BQ-123 (selective endothelin A receptor antagonist)|Drug: 0.9 % saline|Drug: Nifedipinehttps://ClinicalTrials.gov/show/NCT00722215
140597140597Study Evaluating the Safety and Pharmacokinetics (PK) of Ascending Single IV Doses of ERB-257 in Healthy Japanese MalesCompletedNo Results AvailableHealthy SubjectsDrug: ERB-257|Other: placebohttps://ClinicalTrials.gov/show/NCT00722202
140598140598Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of MycosesCompletedNo Results AvailableSkin Mycoseshttps://ClinicalTrials.gov/show/NCT00722189
140599140599Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020CompletedNo Results AvailableSchizophreniaDrug: BL-1020|Drug: BL-1020 10-30 mg|Drug: risperidonehttps://ClinicalTrials.gov/show/NCT00722176
140600140600A Randomized Controlled Trial of Individual Therapy for First Episode PsychosisRecruitingNo Results AvailablePsychosisOther: Cognitive Behavioural Therapy|Other: befriendinghttps://ClinicalTrials.gov/show/NCT00722163
140601140601Artemisinin Resistance in Cambodia IICompletedNo Results AvailableFalciparum MalariaDrug: Artesunate|Drug: Artesunate|Drug: Artesunatehttps://ClinicalTrials.gov/show/NCT00722150
140602140602Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell LymphomaActive, not recruitingHas ResultsMantle Cell LymphomaDrug: Rituximab 375 mg/m^2|Drug: Cyclophosphamide 750 mg/m^2|Drug: Doxorubicin 50 mg/m^2|Drug: VELCADE 1.3 mg/m^2|Drug: Prednisone 100 mg/m^2|Drug: Vincristine 1.4 mg/m^2https://ClinicalTrials.gov/show/NCT00722137
140603140603S-Adenosyl-L-Methionine (SAMe) for Smoking AbstinenceCompletedHas ResultsTobacco DependenceDrug: S-Adenosyl-L-Methionine|Drug: S-Adenosyl-L-Methionine|Other: placebohttps://ClinicalTrials.gov/show/NCT00722124
140604140604Exercise for Swallowing Problems After StrokeCompletedNo Results AvailableCerebrovascular Accident|Deglutition DisordersDevice: lingual press|Behavioral: effortful swallowing|Behavioral: natural swallowing|Behavioral: non-oral sham (control) exercisehttps://ClinicalTrials.gov/show/NCT00722111
140605140605Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma PatientsTerminatedNo Results AvailableMalignant Melanoma Stage IVBiological: DC Vaccine & Cyclophosphamide|Biological: DC Vaccine & Placebohttps://ClinicalTrials.gov/show/NCT00722098
140606140606Amniotic Fluid Sludge in Cerclage Patients as an Indicator for Increased Risk of Preterm Delivery and Neonatal Outcome.CompletedNo Results AvailableHigh Risk Pregnancy|Incompetent Cervix|Cerclage|Amniotic Fluid Sludge|Gestation Age at Delivery.https://ClinicalTrials.gov/show/NCT00722085
140607140607Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor TherapyTerminatedHas ResultsBreast CancerDrug: fulvestrant|Drug: sorafenib tosylatehttps://ClinicalTrials.gov/show/NCT00722072
140608140608Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital MammographyCompletedNo Results AvailableBreast Neoplasms|Breast AbnormalitiesProcedure: Breast Tomosynthesishttps://ClinicalTrials.gov/show/NCT00722059
140609140609Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer's DiseaseBiological: PF-04360365 0.1 mg/kg|Biological: PF-04360365 0.5 mg/kg|Biological: PF-04360365 1 mg/kg|Drug: Placebo|Biological: PF-04360365 3 mg/kg|Biological: PF-04360365 8.5 mg/kghttps://ClinicalTrials.gov/show/NCT00722046
140610140610Common Neonatal Procedures Could Affect the aEEG in - Not yet recruitingNo Results AvailableRegional Blood Flow|Premature Birth|ElectroencephalographyDrug: 3 protocols of Indomethacin administrationhttps://ClinicalTrials.gov/show/NCT00722033

* Görseller ve İçerik tekif hakkına sahip olabilir